The global epidemic of obesity and its associated risks of chronic diseases, including type 2 diabetes, pose formidable challenges to human health. Classical brown adipose tissue (BAT) found prominently in rodents and hibernating mammals dissipates extra energy to generate heat through uncoupled respiration mediated by UCP1 and thus increases energy expenditure and counteracts obesity [1] [2] [3] [4] . Metabolically active UCP1 + brown adipocytes have been detected recently in adult humans with advanced imaging techniques [5] [6] [7] [8] [9] . Interestingly, human adipose depots are highly heterogeneous, and brown adipocytes coexist with white and beige (brown-in-white, or brite) adipocytes [10] [11] [12] . Beige adipocytes are a class of adaptive thermogenic cells located within various depots of WAT [13] [14] [15] [16] [17] . Recent studies have indicated that beige adipocyte homeostasis can be maintained through two mechanisms. First, they can be generated de novo from a population of beige preadipocytes 18, 19 . Second, they can be bi-directionally converted from and to white adipocytes under the control of environmental temperature or sympathetic nerve innervation [20] [21] [22] . Elevated UCP1 expression in cold-acclimated beige adipocytes is associated with robust uncoupled respiration and thermogenesis 23 . Notably, the appearance of beige or brown adipocytes in humans is inversely correlated with obesity and type 2 diabetes mellitus 24, 25 , indicating the important role of these adipocytes in regulating metabolism. Thus, identifying the mechanisms underlying beige adipocyte biogenesis is instrumental in the development of therapeutics to reduce adiposity and the risk of obesity-related metabolic syndrome, which affects over 10% of the world population.
Notch signaling is activated by binding of Dll or Jag family ligands with Notch receptors (Notch1-Notch4), leading to γ-secretase-mediated proteolytic cleavage and the release of Notch intracellular domain (NICD) 26 . NICD then translocates to the nucleus, where it binds with the Rbpj transcriptional complex to activate the transcription of downstream targets, including Hes and Hey family genes. Paradoxically, Notch signaling has been shown to either inhibit or facilitate the adipogenic differentiation of 3T3-L1 cells [27] [28] [29] [30] . In mouse and human primary cell cultures, Notch inhibition promotes, whereas Notch activation inhibits, adipogenic differentiation of mesenchymal and adipose-derived stem cells [31] [32] [33] . However, genetic ablation of several key components of the signaling pathway has indicated that Notch signaling is dispensable for the adipogenesis of mouse embryonic stem cells or embryonic fibroblasts derived from early embryos 34 . As these studies were conducted in cultured cells, the function of Notch signaling in adipose tissues in vivo remains unknown. Here we report that the Notch pathway inhibits browning of white adipose tissue and regulates body energy homeostasis in vivo. This finding opens a new avenue to understand the molecular control of adipose plasticity and develop therapeutics to treat the emerging epidemics of obesity and diabetes through inhibition of Notch signaling transduction.
RESULTS
White-to beige-fat transition in Notch-signaling mutant mice We first examined the relative expression of Notch pathway genes in different depots of WAT from wild-type (WT) mice. Notably, the mRNA levels of Notch receptors and Notch targets were much higher in visceral epididymal WAT (EpiWAT) than in subcutaneous inguinal WAT (IngWAT) (Supplementary Fig. 1a,b) . By contrast, the BATspecific genes Ucp1, Ppargc1a and Prdm16 were expressed at lower levels in EpiWAT than in IngWAT (Supplementary Fig. 1c) . We also observed an inverse correlation between activated Notch1 (N1ICD) and Ucp1 at the protein level (Supplementary Fig. 1d ). These results suggest that Notch signaling may have a role in regulating BAT-specific gene expression in vivo.
To directly investigate how Notch signaling regulates adipose plasticity in vivo, we established an adipose-specific Notch1 knockout mouse model: aP2-cre/Notch1 flox/flox , henceforth referred to as aNotch1. To validate the tissue specificity of aP2-cre, we evaluated YFP fluorescence in different organs of aP2-cre/Rosa eYFP reporter mice. As expected, all adipocytes were YFP + , but liver and muscle tissues, two important regulators of lipid and glucose homeostasis, were predominately YFP − with only a few YFP + interstitial cells (Supplementary Fig. 2a ). Adipose macrophages, accounting for <2% of the total stromal vascular fraction (SVF) cells, were also predominantly YFP − (Supplementary Fig. 2b,c) . PCR-based genotyping confirmed DNA recombination in the adipose tissues of aNotch1 mice (Supplementary Fig. 2d ). Accordingly, Notch1 expression was ~65% lower in adipose tissues and 85% lower in mature adipocytes but was unchanged in other tissues of aNotch1 mice compared to WT mice (Supplementary Fig. 2e) . Notably, various depots of subcutaneous WAT of aNotch1 mice appeared browner than their WT counterparts (Fig. 1a) . In addition, the weight of various fat depots was lighter in aNotch1 compared to WT mice (Fig. 1b) . Furthermore, multilocular Ucp1 + beige adipocytes were much more abundant in the IngWAT of aNotch1 compared to WT mice (Fig. 1c) . The average adipocyte sizes of WAT in aNotch1 mice were ~40% smaller than those in WT mice (Fig. 1c) . At the molecular level, the expression of Ucp1, Cidea, Prdm16 and Ppargc1a was higher in the IngWAT of aNotch1 compared to WT mice (Fig. 1d) . Western blot analysis confirmed the higher Ucp1 protein levels in the IngWAT of aNotch1 mice compared to WT mice (Fig. 1e) . In addition, mRNA levels of beige cell markers (Cd137, also called Tnfrsf9, and Tbx1), mitochondria genes (Cpt1a and Cpt2) and lipolysis enzymes (Atgl, also called Pnpla2, and Hsl, also called Lipe) were all considerably higher in the IngWAT of aNotch1 mice than WT mice (Fig. 1f) . We observed similar browning phenotypes in visceral EpiWAT but not BAT of aNotch1 mutant mice ( Supplementary Fig. 2f-h) .
In parallel we generated another mouse model, aP2-cre/Rbpj flox/flox (aRbpj). Genotyping and quantitative PCR (qPCR) confirmed deletion of Rbpj DNA and lower expression levels of Rbpj mRNA in adipose tissues of aRbpj as compared to WT mice ( Supplementary  Fig. 2d,i) . We again observed a browner appearance of IngWAT in aRbpj compared to WT mice (Fig. 1g) , which was associated with higher expression levels of BAT-specific genes (Fig. 1h) . However, expression of these genes was not altered in the BAT (Supplementary Fig. 2i ). Of note, the aNotch1 and aRbpj mice both had higher rectal temperatures than their WT siblings (Fig. 1i,j) , indicating that the higher Ucp1 expression levels result in elevated thermogenesis in vivo.
Improved glucose metabolism in Notch-signaling mutant mice In rodents and humans, brown adipocytes have been shown to improve glucose metabolism and insulin sensitivity 35, 36 . To check whether browning of WAT in aNotch1 mice elicits beneficial metabolic effects, we conducted intraperitoneal glucose-and insulin-tolerance tests (IP-GTT and IP-ITT, respectively). Compared to their WT siblings, aNotch1 mice had lower blood glucose concentrations after glucose or insulin injection (Fig. 2a,b) . We further measured npg insulin-stimulated glucose uptake by IngWAT explants and found that IngWAT from aNotch1 mice absorbed ~65% more glucose than that from WT mice (Fig. 2c) . We also observed improved glucose tolerance and insulin-stimulated glucose clearance in aRbpj compared to WT mice (Fig. 2d,e) . These in vivo and ex vivo experiments together suggest that genetic disruption of Notch signaling in adipose tissue improves insulin sensitivity and blood glucose tolerance. A physiological characteristic of beige cells is their highly active metabolism coupled to thermogenesis. We examined the metabolic rate of aNotch1 mice using an indirect calorimetry approach. aNotch1 mice had higher rates of oxygen (O 2 ) consumption and carbon dioxide (CO 2 ) production and expended more energy than WT mice despite similar motor behaviors ( Fig. 2f-h and Supplementary Video 1). To examine whether the metabolic changes were dependent on Ucp1 function, we acclimated mice at thermoneutral conditions (28.3 °C) for 3-5 weeks to block the functional activation of Ucp1. Notably, thermoneutrality abolished the beneficial metabolic phenotypes of the aNotch1 mice observed at room temperature but not Ucp1 protein expression (Supplementary Fig. 3 ). This result suggests that the browning of WAT in aNotch1 mice leads to Ucp1-dependent improvements of energy expenditure.
Contrary to thermoneutrality, cold stress induces the formation of beige adipocytes and their adaptive thermogenesis through UCP1 upregulation and sympathetic nerve stimulation 37 . Notably, IngWAT of aNotch1 mice contained many more clusters of Ucp1 + cells than IngWAT from WT mice after exposure to 4 °C for 1 week (Fig. 2i) . In addition, adipocytes in the IngWAT from aNotch1 mice were predominantly multilocular and Ucp1 + , whereas that from WT mice only contained a small fraction of such cells (Fig. 2i) . These morphological changes were associated with elevated expression of Ucp1 and Pgc1-α (encoded by Ppargc1a) in IngWAT from cold-acclimated aNotch1 mice compared to that from WT mice under similar conditions (Fig. 2j) .
These results indicate that aNotch1 mice are more adaptive than WT mice to cold-induced thermogenesis.
The aNotch1 mice are resistant to high fat diet-induced obesity In light of their better glucose tolerance, insulin sensitivity and higher metabolic rate compared to WT mice, we predicted that aNotch1 mice should be resistant to high-fat diet (HFD)-induced obesity. Indeed, aNotch1 mice were leaner after being fed HFD for 4 weeks (Fig. 3a) even though their daily energy intake was similar to that of their WT littermates (Fig. 3b) . In addition, the aNotch1 mice retained better glucose tolerance and higher insulin sensitivity after HFD feeding compared to WT mice (Fig. 3c,d ).
This observation prompted us to examine whether HFD activates Notch signaling in WT mice. After HFD feeding, the expression of Lep, a surrogate indicator of mature adipocytes and obesity, was increased 20-fold ( Fig. 3e) , confirming the obesogenic effect of HFD. Coincidentally, mRNA and protein expression of Notch receptors and targets was induced by HFD (Fig. 3e,f) . These results together suggest that activation of Notch signaling is associated with, and inactivation of Notch conversely prevents, HFD-induced obesity.
Adipocyte-specific activation of Notch signaling inhibits browning and glucose metabolism As a complementary approach to the knockout mouse models, we carried out gain-of-function studies using adiponectin (Adipoq)-cre/Rosa N1ICD mice (henceforth called Adipoq/N1ICD). As expected, the adipose tissue of Adipoq/N1ICD mice had higher expression levels of N1ICD, Hes1 and Hey1 compared to that of WT mice (Fig. 4a) . The Adipoq/N1ICD mice were slightly (~6%) heavier than their WT littermates even though they had similar food intake ( Supplementary Fig. 4a,b) .
Notably, the Adipoq/N1ICD mice had lower glucose tolerance and insulin sensitivity compared with WT littermates (Fig. 4b,c) . In addition, the metabolic rate and body temperature of Adipoq/N1ICD mice were also lower than those in WT mice ( Fig. 4d-g ) and were accompanied by lower expression levels of thermogenic and mitochondrial respiration-related genes in the IngWAT but not BAT (Fig. 4h,i) . Furthermore, BAT from Adipoq/N1ICD mice accumulated more lipid droplets, and the size of the lipid droplets appeared larger than those in BAT from WT mice (Fig. 4j) . Compared to the WT mice, the Adipoq/N1ICD mice were also less responsive to cold-induced browning, as manifested by a lower abundance of Ucp1 + beige adipocytes and lower expression levels of Ucp1 and Pgc1-α proteins in IngWAT after being acclimated to 4 °C ( Supplementary Fig. 4c,d) .
Thus, genetic activation of Notch signaling in adipocytes impairs body energy metabolism.
Notch signaling inhibits the expression of Prdm16 and Ppargc1a in white adipocytes
To understand the cellular and molecular mechanisms through which Notch signaling regulates adipocytes, we first employed lossof-function studies in cell culture. We cultured SVF preadipocytes from subcutaneous WAT of Notch1 flox/flox mice. After transfection with a Cre plasmid, the expression of Notch1 and its downstream target Hes1 were reduced by more than 50% (Fig. 5a ), which was accompanied by an upregulation of Prdm16 and Ppargc1a expression (Fig. 5a ). In parallel, we inhibited Notch signaling in white adipocytes from WT mice with the γ-secretase inhibitor DAPT. DAPT upregulated the expression of Ucp1, Cidea, Prdm16 and Ppargc1a ( Fig. 5b and Supplementary Fig. 5a,b) . Similarly, adipocytes cultured from IngWAT of aNotch1 mice expressed higher levels of Ucp1, Ppargc1a and Prdm16 than adipocytes from WT mice ( Supplementary  Fig. 5c,d) . Moreover, inguinal adipocytes from aNotch1 mice exhibited higher O 2 consumption rate (OCR) than those from WT mice after stimulation with palmitate ( Supplementary Fig. 5e ). These results demonstrate that inhibition of Notch signaling enhances the expression of brown (beige) adipocyte-specific genes and the cellular respiration of white adipocytes in a cell-autonomous manner.
We also performed Notch gain-of-function studies by using SVF cells isolated from the subcutaneous WAT of Rosa N1ICD mice and then transfecting them with GFP (control) or Cre plasmids. Compared to the control group, Cre-transfected SVF cells expressed higher levels of N1ICD, Hes1 and Hey1 but lower levels of Prdm16 and Ppargc1a (Fig. 5c) . Overexpression of Hey1 or Hes1 alone in SVF cells of WT mice similarly led to lower levels of Prdm16 and Ppargc1a as compared to the control (GFP) treatment (Fig. 5d,e) . Together, activation of N1ICD or overexpressing Notch target genes suppressed the expression of the brown fat-associated genes Prdm16 and Ppargc1a. These results prompted us to ask whether the transcriptional repressor Hes1 can directly bind the promoter of Prdm16 and Ppargc1a. Bioinformatics analysis identified consensus N-box (CACNAG) sites in the proximal promoter regions of mouse and human PRDM16 and PPARGC1A (Fig. 5f) . Chromatin immunoprecipitation (ChIP) using a Hes1-specific antibody followed by qPCR assay using primers flanking the N-box region showed that these predicted binding sites in the Prdm16 and Ppargc1a promoter regions were enriched by 3-and 13-fold, respectively (Fig. 5g) . However, enrichment of these regions was abolished in adipocytes from aNotch1 mice (Fig. 5g) . As a control, the Hes1-specific antibody failed to enrich random promoter regions that do not contain the N-box sequence (Fig. 5g) , confirming the specificity of Hes1 binding to the N-box. Furthermore, Hes1 overexpression inhibited Ppargc1a promoter-driven luciferase reporter activity (Fig. 5h) . These results suggest that the canonical Notch target Hes1 can bind directly to the promoters of Prdm16 and Ppargc1a to repress their expression, thereby inhibiting brown (beige) gene programs.
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Notch inhibition induces browning and ameliorates obesity in
Lep ob mice To explore the therapeutic potential of targeting Notch signaling to improve glucose metabolism, we treated WT mice with a pharmacological inhibitor of Notch signaling. We injected littermate mice of similar body weight with dibenzazepine (DBZ), another γ-secretase inhibitor, or vehicle control for 5 days consecutively. Notably, DBZtreated mice had better glucose tolerance and insulin sensitivity than control mice (Supplementary Fig. 6a,b) . At the molecular level, DBZ treatment resulted in higher Ucp1 mRNA and protein expression in IngWAT and EpiWAT compared to vehicle treatment ( Supplementary  Fig. 6c,d) . Adipocyte volume and number are positively correlated with leptin production 38 , and we found lower Lep expression and less adiposity but a higher number of Ucp1 + adipocytes in DBZ-treated mice than in control mice (Supplementary Fig. 6e,f) . Hence, Notch inhibition reduced adiposity and improved glucose homeostasis in healthy mice.
To further investigate whether Notch inhibition ameliorates obesity under pathological conditions, we treated ob/ob mice deficient in Lep (Lep ob ) with DBZ. We grouped the mice randomly, and the groups showed no difference in body-weight gain before treatment (Fig. 6a) . Notably, DBZ treatment attenuated the body-weight gain seen in the vehicle-treated control group without affecting energy intake (Fig. 6a,b) . The body-weight differences were associated with smaller npg size and less weight of various WAT depots in the DBZ-treated compared to vehicle-treated mice (Fig. 6c-e and Supplementary  Fig. 7a,b) . DBZ-treated mice also had lower liver weight and less hepatic lipid accumulation ( Fig. 6d and Supplementary Fig. 7a ), which are consistent with previous observations that Notch promotes lipogenesis in hepatocytes and liver steatosis 39 . In addition, glucose tolerance and insulin sensitivity were improved by DBZ treatment (Fig. 6f) . Consistent with reduced adiposity, DBZ-treated mice showed a lower respiration exchange ratio compared with control mice (Fig. 6g) , indicating that DBZ initiated a metabolic shift toward the utilization of fat as the energy source. At the molecular level, DBZ inhibited the expression of the Notch targets Hes1, Hey1 and Heyl as well as Lep (Fig. 6h) but upregulated the expression of Ucp1 and Ppargc1a in WAT (Fig. 6h) . DBZ also suppressed the expression of the inflammatory cytokines encoded by Cd68, Il6 and Il1b (Fig. 6i) that are associated with obesity in humans 40 . At end of the experiment, fed blood glucose concentrations remained low in the absence of DBZ injection (Fig. 6j) , suggesting a long-term beneficial effect of adipose browning on glucose metabolism. These results together provide strong evidence that the Notch signaling pathway can be pharmacologically targeted to prevent and treat obesity and improve glucose tolerance and insulin sensitivity.
DISCUSSION
Our study reveals a previously unrecognized yet critical role of Notch signaling in regulating the browning of adipose tissues and body insulin sensitivity. We have provided compelling genetic, physiological, metabolic, histological, cellular and molecular evidence to demonstrate that blockage of Notch signaling promotes the browning of WAT. Conversely, activation of Notch signaling represses the expression of genes critical for BAT biogenesis and is associated with whitening of BAT and poor insulin sensitivity. As Notch signaling is highly conserved in the animal kingdom, we anticipate that our results in mice will be applicable to humans, although future studies dissecting the role of Notch signaling in human adipose tissues will be imperative.
We used aP2-cre mice to drive the deletion of Notch1 or Rbpj in adipose tissues. Although the aP2-cre expression domain falls predominantly in immature and mature adipocytes, leaky expression of this promoter has been reported in several other cell types [41] [42] [43] [44] . Coincidently, Notch inhibition has been shown to improve insulin sensitivity through regulating liver glucose metabolism and attenuating atherosclerosis 45, 46 . Even though we used a more adipocyte-restricted Adipoq-cre mouse model 47 to show that Notch activation conversely induces whitening of BAT and reduces glucose tolerance, we cannot exclude the possibility that Notch signaling in other cell types may have also contributed to the metabolic improvements of the aNotch1 mice.
The white-to brown-fat transition involves a series of cellular processes, including increased Ucp1 expression, mitochondria production, lipolysis and β-oxidation. These features are all observed in the WAT but not BAT of Notch mutant mice. The differential responses of BAT and WAT to Notch signaling are perhaps due to the different npg embryonic origins of these tissues, as well as cell type-specific gene regulatory programs. Of note, the higher Ucp1 level in white adipocytes from aNotch1 mice was associated with enhanced uncoupled respiration and thermogenesis, which may have led to a higher core body temperature. However, as mammalian body temperature is controlled by the central nervous system, the subtle increases in core body temperature in Notch mutants suggest that Notch signaling may also have a role in central nervous system-mediated body temperature regulation. Alternatively, as both Notch signaling and core body temperature exhibit circadian rhythms (i.e., they oscillate during a day) 48, 49 , perturbations in Notch signaling may have altered the normal rhythm of core body temperature. We used ChIP assay to demonstrate that the transcriptional co-repressor Hes1 binds directly to the promoter regions of Ppargc1a and Prdm16, whose expression is inhibited by Hes1 overexpression. Hey proteins can also inhibit the expression of Hes1 targets through dimerization with Hes1 (ref. 50) . Consistent with this notion, we observed that overexpression of Hey1 also inhibited the transcription of Ppargc1a and Prdm16. In addition, NICD may recruit Gcn5 (also called Kat2a), a cofactor of the Rbpj transcription complex 51 and a major acetyltransferase of Pgc1-α, to repress its transcriptional activity 52 . Contradictory to our finding, Hes1 has been shown to positively regulate the expression of Prdm16 during mouse neurogenesis 53 . As Hes1 is a canonical transcriptional repressor, it probably acts through other mediators to upregulate Prdm16 indirectly in the neural system. These observations underscore the importance of cell context-dependent action of Notch signaling 54 .
We found that HFD increased Notch activity in WAT, and aNotch1 mutants were resistant to HFD-induced obesity. These results indicate that activation of Notch signaling is linked to the initiation and development of obesity. Our observation is in agreement with a recent study showing that a high-fat, high-cholesterol diet increases the expression of Dll4 (a Notch ligand) in the atheroma and fat tissue of Ldlr-deficient mice 46 . It is currently unclear how Notch signaling is activated at the onset of obesity. In addition, a recent study showed that excessive leptin production in mice with diet-induced obesity activates Notch signaling in metastatic breast cancer cells 55 . As we observed that inhibition of Notch reduced the expression of Lep in adipose tissues, it is possible that a positive feedback loop between Notch signaling and excessive leptin production together accelerates the development of obesity. Treating Lep ob mice with γ-secretase inhibitor reduced body weight and ameliorated glucose metabolism, and such a drastic effect may be elicited not only by browning of white adipocytes but also through targeting of other important metabolic organs, including the liver and intestine, which directly regulate lipid metabolism and nutrient absorption, respectively 39, 56 . Pharmacological approaches targeting adipose tissue specifically will clarify the direct contribution of adipose tissue to metabolic improvements after Notch inhibition.
One important future question is whether Notch signaling is involved in the commitment and specification of progenitors to become beige or classical white adipocytes. Several lines of evidence suggest that browning is an inherent capability that is restricted to a certain cell population that has a standby or predisposed machinery to respond to browning cues 19, 57 . As Notch signaling is widely employed to control cell fate during development, it is important to examine how Notch regulates the cell fate specification of embryonic beige progenitors.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
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We thank T. Honjo (Kyoto University, Japan) for providing the Rbpj flox/flox mice; Dow AgroScience for providing Methocel E4M reagent; K. Ajuwon for providing access to the calorimetry facility; S. Koser and S. Donkin for assistance with luciferase assays; D. Zhou for Odyssey imaging facility support; T. Wiegand and C. Bain for assistance with histology; J. Wu and S. Hobaugh for maintaining mouse colonies; and members of the Kuang laboratory for comments. This work was partially supported by a grant from the US National Institutes of Health (R01AR060652 to S.K.). H&E and immunohistochemistry staining. Adipose tissues were fixed in 10% formalin for 24 h at room temperature. Then the tissues were embedded into paraffin and cut into 4-µm thick slices, deparaffinized and rehydrated using xylene, ethanol and water by standard methods. For antigen retrieval, slides were submerged in 0.01 M sodium citrate (pH 6.0) and heated to 96 °C for 20 min in a laboratory microwave (PELCO). Immunohistochemistry was performed on a Dako Autostainer (Dako, Carpinteria, CA). Slides were incubated with 3% hydrogen peroxide and 2.5% normal horse serum (S-2012, Vector), followed by incubation with rabbit polyclonal anti-UCP1 primary antibody diluted 1:200 in 2.5% normal horse serum (Vector, S-2012) for 60 min. Signals were detected with an anti-rabbit IgG Polymer Detection Kit (MP-7401, Vector). Labeling was visualized with 3,3′-diaminobenzidine (DAB) as the chromogen (SK-4105, Vector). Slides were counterstained with Harris hematoxylin (EK Industries, Joliet, IL), and whole-slide digital images were collected at 20× magnification with an Aperio Scan Scope slide scanner (Aperio, Vista, CA). Images shown are representative results of at least three biological replicates. Scanned images of H&E staining were analyzed by Photoshop CS3 to calculate cell numbers. Average adipocyte size was calculated as the image area divided by the cell number.
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ChIP and genomic DNA recombination assay. Cultured inguinal adipocytes of both WT and mutant mice were crosslinked with 1% formaldehyde in DMEM for 10 min at room temperature followed by the addition of 125 mM glycine for 5 min at room temperature, after which cells were washed once with ice-cold PBS and scraped into SDS lysis buffer. The cells were further sonicated and diluted for immunoprecipitation with the indicated antibodies. The immunoprecipitates were eluted and reverse crosslinked overnight at 65 °C. DNA fragments were purified using the Cycle Pure kit (Omega Bio-Tek), and qPCR was performed with the primers listed in Supplementary Luciferase assay. HEK293A cells were seeded into 12-well plates 1 d before Lipofectamine 2000-mediated transfection. The PGC1-α promoter luciferase plasmid was purchased from Addgene and generated by Handschin et al. 68 . For transfection of each well, 100 ng Renilla plasmid, 400 ng pGL3-Basic (or pGL3-PGC1-α) and 600 ng Hes1 plasmid (or its blank control plasmid) were co-transfected following the manufacture's instructions. Cells were harvested 36 h after transfection and analyzed with the Dual-Luciferase Reporter Assay System (Promega).
Statistical analyses.
Trial experiments or experiments done previously were used to determine sample size with adequate statistical power. Measurement values that were beyond the boundary determined by the interquartile range were considered as outliers and were excluded from statistical analyses. All analyses were conducted with Student's t test with a two-tail distribution. Comparisons with P values <0.05 were considered significant. The researchers involved in the study were not completely blinded during sample obtainment or data analysis.
